Application prospect of peptide-modified nano targeting drug delivery system combined with PD-1/PD-L1 based immune checkpoint blockade in glioblastoma-Reference-Cited by-同舟云学术

Application prospect of peptide-modified nano targeting drug delivery system combined with PD-1/PD-L1 based immune checkpoint blockade in glioblastoma

Published:2020-11 Issue: Volume:589 Page:119865
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Song Panpan,Zhao Xia,Xiao Sa

Funder

Qingdao National Laboratory for Marine Science and Technology

National Natural Science Foundation of China-Shandong Joint Fund for Marine Science Research Centers

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference103 articles.

1. Identification of a novel role of IL-13Ralpha2 in human glioblastoma multiforme: Interleukin-13 mediates signal transduction through AP-1 pathway;Bhardwaj;J. Transl. Med.,2018

2. Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages;Bloch;Clin. Cancer Res.,2013

3. Comparison of five peptide vectors for improved brain delivery of the lysosomal enzyme arylsulfatase A;Bockenhoff;J. Neurosci.,2014

4. Nivolumab versus docetaxel in advanced squamous-cell non–small-cell lung cancer;Brahmer;N. Engl. J. Med.,2015

5. Safety and activity of anti–PD-L1 antibody in patients with advanced cancer;Brahmer;N. Engl. J. Med.,2012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent progress in multifunctional conjugated nanocarriers for photodynamic therapy of tumors;Nanophototherapy;2025

2. Chitosan nanoparticle delivery systems: An effective approach to enhancing efficacy and safety of anticancer drugs;Nano TransMed;2024-12

3. Experimental design and characterization of dual-antibody-conjugated all-trans retinoic acid-loaded lipid nanoparticles as a potential cancer therapy;Journal of Drug Delivery Science and Technology;2024-10

4. Current approaches in glioblastoma multiforme immunotherapy;Clinical and Translational Oncology;2024-03-21

5. Glioblastoma Therapy: Past, Present and Future;International Journal of Molecular Sciences;2024-02-21